u/honest_syringe19

personal-import allowances differ by country

Yes, exactly this, and it is the bit that took me 42 weeks to accept.

Maintenance for 8 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

Which plan type? denial is different.

Small correction: the trial was 13 weeks, not 24. Does not change your point but people will quote it.

Correct.

Adding to this: testing is doing more work than the comment implies.

transit time variance is the story, not the average

This is correct. Long-term logs matter.

the carve-out clause varies by employer

say which country and which plan type

That is net peptide content, not purity. Different number, different meaning.

say which country and which plan type

Disagree but this is the good kind of wrong — it is specific enough to be checked.

Strongly agree. Step therapy is predictable if you have the criteria.

Is that a PeptideMeter result or are you quoting the vendor COA?

Strongly agree. Step therapy is predictable if you have the criteria.

no advice on evading inspection or misdeclaring

Sweden here. Waited 24 months on a list, gave up, went private, and the total cost was roughly what I expected.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

This is correct. Appeal letters work.

prior auth criteria are state-specific, external review differs